AAMU
COLL icon

Amundi Asset Management US’s Collegium Pharmaceutical COLL Stock Holding History

Amundi Asset Management US’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,482
Closed -$533K – 1607
2020
Q2 		$533K Hold
30,482
– – ﹤0.01% 1245
2020
Q1 		$498K Hold
30,482
– – ﹤0.01% 1203
2019
Q4 		$627K Buy
+30,482
New +$508K ﹤0.01% 1306

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Amundi Asset Management US's COLL Position: Q3 2020 in Review

Amundi Asset Management US sold out of Collegium Pharmaceutical (COLL) in Q3 2020, closing a stake of 30,482 shares — an estimated $533K sold.

Amundi Asset Management US first reported a position in COLL in Q4 2019 and held it in 3 quarters. The position peaked at $627K in Q4 2019. 140 funds tracked by Wall St. Rank hold COLL as of Q3 2020.

  • Amundi Asset Management US reported no remaining Collegium Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • Amundi Asset Management US sold 30,482 Collegium Pharmaceutical shares in Q3 2020, an estimated $533K.
  • Amundi Asset Management US first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 3 quarters.
  • Amundi Asset Management US's Collegium Pharmaceutical position peaked at $627K in Q4 2019.
  • 140 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2020.

Based on Amundi Asset Management US's 13F filing for Q3 2020, filed 16 Nov 2020.